Denali Therapeutics Inc.
Clinical trials sponsored by Denali Therapeutics Inc., explained in plain language.
A biopharmaceutical company developing therapies for neurodegenerative diseases.
Trade on eToro (ad)Not investment advice. Company information is shown for context only. Clinical trials frequently fail.
-
New Alzheimer's drug enters early human testing
Disease control Recruiting nowThis study is testing an experimental drug called DNL628 in people with early-stage Alzheimer's disease. The main goal is to see if the drug is safe and how the body processes it. About 68 participants will receive either DNL628 or a placebo. This is an early-phase trial, so it f…
Phase: PHASE1 • Sponsor: Denali Therapeutics Inc. • Aim: Disease control
Last updated Jul 03, 2026 00:00 UTC
-
New drug DNL952 enters human testing for pompe disease
Disease control Recruiting nowThis early-stage trial is testing a new drug called DNL952 in 32 adults with late-onset Pompe disease. The main goal is to check if the drug is safe and how the body processes it. Participants will receive the drug through an IV infusion at different doses.
Phase: PHASE1 • Sponsor: Denali Therapeutics Inc. • Aim: Disease control
Last updated Jul 01, 2026 00:00 UTC